Are you Dr. Kim?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 60 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
# Bidmc
Boston, MA 02215Phone+1 617-667-3753
Summary
- Dr. Caroline Kim, MD is a board certified dermatologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is affiliated with Newton-Wellesley Hospital.
Education & Training
Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 2002 - 2005
Brigham and Women's HospitalInternship, Internal Medicine, 2001 - 2002
Harvard Medical SchoolClass of 2001
Certifications & Licensure
MA State Medical License 2005 - 2026- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Publications & Presentations
PubMed
- 22 citationsClinicopathologic, misdiagnosis, and survival differences between clinically amelanotic melanomas and pigmented melanomas.Lauren C. Strazzulla, Xiaoxue Li, Kathleen Zhu, Jean-Phillip Okhovat, Sandra J. Lee
Journal of the American Academy of Dermatology. 2019-05-01 - 27 citationsPrognostic gene expression profiling in melanoma: necessary steps to incorporate into clinical practice.Douglas Grossman, Caroline C. Kim, Rebecca I. Hartman, Elizabeth G. Berry, Kelly C. Nelson
Melanoma Management. 2019-12-17 - 50 citationsUsing deep learning for dermatologist-level detection of suspicious pigmented skin lesions from wide-field images.Luis R. Soenksen, Timothy Kassis, Susan T. Conover, Berta Marti-Fuster, Judith S. Birkenfeld
Science Translational Medicine. 2021-02-17
Authored Content
- Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020
- Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020
- Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020
Press Mentions
Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but with Positive Histologic MarginsDecember 1st, 2019
BIDMC Research & Health News Digest: October 2018November 1st, 2018
New Data Provides Guidance for Management of Moderately Dysplastic MolesOctober 25th, 2018- Join now to see all
Professional Memberships
- Fellow
